# Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion Subsets

Study · id `cardio:ct-nct01670318` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01670318](<https://clinicaltrials.gov/study/NCT01670318>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01670318

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 800 participants.

## Technical summary

Registry record NCT01670318. Non-randomized; no masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 800 participants (planned count; ClinicalTrials.gov record NCT01670318, source copy `cardio:ctgov-nct01670318-2012-08-22`, retrieved 2026-10-26)
- Start date: 2012-08 (registry gives no type) (ClinicalTrials.gov record NCT01670318, source copy `cardio:ctgov-nct01670318-2012-08-22`, retrieved 2026-10-26)
- Primary completion: 2013-12 (anticipated) (ClinicalTrials.gov record NCT01670318, source copy `cardio:ctgov-nct01670318-2012-08-22`, retrieved 2026-10-26)
- Completion: 2015-12 (anticipated) (ClinicalTrials.gov record NCT01670318, source copy `cardio:ctgov-nct01670318-2012-08-22`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT01670318, source copy `cardio:ctgov-nct01670318-2012-08-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01670318-2012-08-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion Subsets
- Acronym: SPECIALIST
- Condition: Coronary Artery Disease
- Intervention (Device): platinum chromium everolimus-eluting stent (PROMUS Element by Boston Scientific, Massachusetts)
- Lead sponsor: The PCI Guideline Research Society
- Lead sponsor class: NETWORK

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: d458d3822cf26bcf07a6f2ff613ad48acc138ad79275aa30a9a5f55a6aaf0037
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
